Clinical Trials Logo

Hyperkinesis clinical trials

View clinical trials related to Hyperkinesis.

Filter by:

NCT ID: NCT04569357 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder

Clinical Trial of Efficacy and Safety of Prospecta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children

Start date: November 20, 2020
Phase: Phase 3
Study type: Interventional

Purpose of the study: • evaluate the efficacy and safety of Prospecta in the treatment of attention deficit/hyperactivity disorder in children.

NCT ID: NCT04569058 Recruiting - Clinical trials for Attention Deficit Hyperactivity Disorder

Transcranial Photobiomodulation Therapy for the Treatment of Autistic Traits in Children and Adolescents With ADHD

Start date: January 14, 2021
Phase: N/A
Study type: Interventional

An open label trial to assess the safety and efficacy of transcranial photobiomodulation (tPBM) in improving autistic traits in ADHD youth.

NCT ID: NCT04561713 Recruiting - Clinical trials for Attention Deficit Hyperactivity Disorder

Virtual Reality and Diagnostic of Attention Deficit Hyperactivity Disorder (ADHD) (PADA1)

PADA1
Start date: July 21, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to develop an application in order to identify the most relevant cognitive and behavioral parameters for the diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) in conditions closer to reality

NCT ID: NCT04532190 Not yet recruiting - Clinical trials for Attention-Deficit/Hyperactivity Disorder (ADHD)

Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder

FAST-ADHD
Start date: August 31, 2022
Phase: N/A
Study type: Interventional

Attention-Deficit/Hyperactivity Disorder (ADHD) is characterized by poor attention, impulsivity, hyperactivity and emotional-motivational dysregulation. Here, we will test if repetitive transcranial magnetic stimulation (rTMS) can reduce the symptoms of ADHD.

NCT ID: NCT04528433 Withdrawn - Clinical trials for Attention Deficit Hyperactivity Disorder

A Randomized Controlled Study of Medical-education-community Collaborated Intervention in Children With ADHD

Start date: October 2021
Phase: N/A
Study type: Interventional

This study is designed to test if the medical-education-community collaborated intervention can reduce the symptoms of children with Attention deficit hyperactivity disorder (ADHD) compared to routine clinical care. Investigators will also evaluate if the intervention will positively affect organizational skills and academic achievement compared to controls.

NCT ID: NCT04519008 Not yet recruiting - Clinical trials for Attention Deficit Disorder With Hyperactivity

Effectiveness and Security Testing of a Mobile App

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

To assess the effectiveness and security of a mobile App (beta version) for self-managing emotion dysregulation in a pragmatic randomized controlled trial with 80 adolescents with attention-deficit/hyperactivity disorder comparing 40 patients with treatment as usual (TAU) with 40 patients with TAU plus the mobile App

NCT ID: NCT04507204 Terminated - Clinical trials for Attention-Deficit/Hyperactivity Disorder

Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

RE-DAX
Start date: July 30, 2020
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate the treatment effectiveness of Adhansia XR at month-2 after initiation, and the effectiveness of Adhansia XR overall and when compared with the active comparator group (Concerta) over time.

NCT ID: NCT04504890 Recruiting - ADHD Clinical Trials

Ocular-vestibular Biomarker Identification for ADHD

Start date: July 16, 2020
Phase:
Study type: Observational

This study intends to establish a relationship between oculovestibular eye tracking measures, measures of ADHD, and medication prescribed for ADHD.

NCT ID: NCT04494230 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder

Motor Proficiency in School Age ADHD: Contribution of Different Comorbidities

Start date: October 1, 2018
Phase:
Study type: Observational [Patient Registry]

In this study, aged 6-10 years, male, right hand dominant, diagnosed with ADHD, accepting to take part in the study and applying to the Child and Adolescent Psychiatry Department between October 1, 2018 - October 1, 2019 were included in the research group.As for the control group, boys between 6-10 years of age with no mental symptoms described by their teachers or parents and showing healthy development were selected by convenience sampling method and snow ball method. Height and weight measurements of all the children participated in the study were performed. The sociodemographic data form prepared by the researchers was completed by both the research and the control group families. In the sample, the Corners' Parent Scale- Revised Short Form (CPS-R:SF) was used to evaluate the severity of ADHD symptoms.The hand preferences of all participants in the research and control groups were evaluated with Edinburgh Handedness Inventory.Motor skills were evaluated with the 2nd Version of Bruininsky-Oseretsky Motor Competence Test (BOT-2).Hand skills were evaluated with the 9-Hole Peg Test.Visual perception skills were evaluated with 3rd Version of Visual Perception Test without Motor Ability (MVPT-3). Pediatric Quality of Life Inventory Parent Form were filled by the parents of children in the research and control groups for quality of life. In the study, there are five groups: ADHD, ADHD + Specific learning disorders, ADHD + Oppositional defiant disorder, ADHD + Anxiety Disorder and children with typical development group.

NCT ID: NCT04467658 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder

Neurophysiological Marker of ADHD in Children

Start date: August 8, 2018
Phase:
Study type: Observational

This study investigated quantitative electroencephalography (QEEG) subtypes as auxiliary tools to assess Attention Deficit Hyperactivity Disorder (ADHD). Patient assessed using the Korean version of the Diagnostic Interview Schedule for Children Version IV and were assigned to one of three groups: ADHD, ADHD-Not Otherwise specified (NOS), and Neurotypical (NT). The investigators measure absolute and relative EEG power in 19 channels and conducted an auditory continuous performance test. The investigators analyzed QEEG according to the frequency range: delta (1-4 Hz), theta (4-8 Hz), slow alpha (8-10 Hz), fast alpha (10-13.5 Hz), and beta (13.5-30 Hz). The subjects were then grouped by Ward's method of cluster analysis using the squared Euclidian distance to measure dissimilarities.